LMTK2 expression significantly decreases in blood samples of patients with PCa versus BPH as compared to control (with high PSA but no PCa), while PSA density value (ng/mL, based on PSA measurement divided by prostate volume) can differentiate PCa from benign prostate disease. The gene discussed is LMTK2; the disease is benign prostatic hyperplasia.